The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, January 30, 2019
One of our key policy priorities is encouraging the timely development and approval of generics and biosimilars.
read more
Thursday, February 08, 2018
ABITEC has executed a multi-year agreement with distribution partner UNIVAR to promote and sell its specialty lipid products into the Canadian market.
read more
Friday, December 29, 2017
Twice a year the federal government publishes the Unified Agenda which provides the American public with insight into regulations under development or...
read more
Tuesday, November 14, 2017
Andreas Bernkop-Schnürch from the Institute of Pharmacy, University of Innsbruck, Austria, is the recipient of the 2017 Gattefossé North America Award...
read more
Tuesday, October 03, 2017
Regen BioPharma scientists have used a standard biochemical assay to determine if some of its small molecules that have been shown to activate NR2F6 ...
read more
Wednesday, September 27, 2017
As an agency dedicated to promoting public health, and as fellow Americans, the staff at the FDA is doing all it can to support the immediate needs of...
read more
The Lubrizol Corporation announces its LifeSciences business continues to invest in its capabilities through planned expansions.
read more
Pharma trends forecasters welcome three new members to the CPhI Expert Panel in 2015: Kurt Nielson (Catalent), Vivek Sharma (Piramal) and Alan ...
read more
CombiLac®, an innovative, co-processed HFE consists of the spray-dried, ternary admixture of alpha-lactose monohydrate, MCC and starch, each ...
read more
Pharma event launches a range of packages for industry partners to implement charity giving.
read more
Wednesday, February 25, 2015
XstalBio Ltd a biologic formulation and drug-delivery company today announced the United States Patent and Trademark Office has issued US Patent, US 8...
read more
Thursday, February 19, 2015
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous ...
read more
Friday, February 13, 2015
A new whitepaper from Malvern Instruments provides detailed guidance on the analytical technologies that help to accelerate oral solid dosage (OSD) ...
read more
Wednesday, February 11, 2015
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division, has announced the launch of its ...
read more
Tuesday, February 03, 2015
Pierre Fabre Pharmaceuticals announce the initiation of a Phase IIa clinical trial program for F17464, a new selective dopamine D3 receptor antagonist...
read more